___

• 1. Lu NF, Jiang L, Zhu B, Yang DG, Zheng RQ, Shao J, et al. Elevated plasma histone H4 levels are an important risk factor for the development of septic cardiomyopathy. Balkan Med J 2020;37:72-8.
• 2. Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth 2010;104:3-11.
• 3. Ruiz-Bailén M, Romero-Bermejo FJ, Rucabado-Aguilar L, Pérez-Valenzuela J, Ferrezuelo-Mata Á, Ramírez-Sánchez M, et al. Myocardial dysfunction in the critically ill patient: is it really reversible? Int J Cardiol 2010;145:615-6.
• 4. Andrijevic L, Milutinov S, Andrijevic, Jokic D, Vukoja M. Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease. Balkan Med J 2017;34:226-31.
• 5. Yalta K, Yalta T. Physically triggered takotsubo cardiomyopathy has a worse prognosis: Potential roles of systemic inflammation and coronary slow flow phenomenon. Int J Cardiol 2017;242:31-2.
• 6. Yalta K, Yilmaztepe M, Zorkun C. Left Ventricular Dysfunction in the Setting of Takotsubo Cardiomyopathy: A Review of Clinical Patterns and Practical Implications. Card Fail Rev 2018;4:14-20.
• 7. Asfar P, Radermacher P. Vasopressin and ischaemic heart disease: more than coronary vasoconstriction? Crit Care 2009;13:169.
• 8. Yalta T, Yalta K. Systemic Inflammation and Arrhythmogenesis: A Review of Mechanistic and Clinical Perspectives. Angiology 2018;69:288-96.